- Home
- MDGL vs CHRD Comparison
MDGL vs CHRD Comparison
Compare MDGL & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- CHRD
- Stock Information
- Founded
- MDGL 2011
- CHRD 2007
- Country
- MDGL United States
- CHRD United States
- Employees
- MDGL N/A
- CHRD N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- CHRD Oil & Gas Production
- Sector
- MDGL Health Care
- CHRD Energy
- Exchange
- MDGL Nasdaq
- CHRD Nasdaq
- Market Cap
- MDGL 6.1B
- CHRD 6.3B
- IPO Year
- MDGL N/A
- CHRD 2010
- Fundamental
- Price
- MDGL $427.05
- CHRD $106.42
- Analyst Decision
- MDGL Strong Buy
- CHRD Strong Buy
- Analyst Count
- MDGL 10
- CHRD 11
- Target Price
- MDGL $474.67
- CHRD $147.64
- AVG Volume (30 Days)
- MDGL 349.9K
- CHRD 796.7K
- Earning Date
- MDGL 10-30-2025
- CHRD 11-05-2025
- Dividend Yield
- MDGL N/A
- CHRD 5.05%
- EPS Growth
- MDGL N/A
- CHRD N/A
- EPS
- MDGL N/A
- CHRD 4.47
- Revenue
- MDGL $515,547,000.00
- CHRD $4,967,177,000.00
- Revenue This Year
- MDGL $394.12
- CHRD N/A
- Revenue Next Year
- MDGL $57.74
- CHRD N/A
- P/E Ratio
- MDGL N/A
- CHRD $23.86
- Revenue Growth
- MDGL 3421.98
- CHRD 19.70
- 52 Week Low
- MDGL $200.63
- CHRD $79.83
- 52 Week High
- MDGL $457.16
- CHRD $140.16
- Technical
- Relative Strength Index (RSI)
- MDGL 59.53
- CHRD 52.58
- Support Level
- MDGL $418.36
- CHRD $101.88
- Resistance Level
- MDGL $440.90
- CHRD $106.75
- Average True Range (ATR)
- MDGL 13.53
- CHRD 3.07
- MACD
- MDGL -4.66
- CHRD -0.24
- Stochastic Oscillator
- MDGL 22.40
- CHRD 48.68
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.